1. Home
  2. STZ vs ARGX Comparison

STZ vs ARGX Comparison

Compare STZ & ARGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STZ
  • ARGX
  • Stock Information
  • Founded
  • STZ 1945
  • ARGX 2008
  • Country
  • STZ United States
  • ARGX Netherlands
  • Employees
  • STZ N/A
  • ARGX N/A
  • Industry
  • STZ Beverages (Production/Distribution)
  • ARGX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • STZ Consumer Staples
  • ARGX Health Care
  • Exchange
  • STZ Nasdaq
  • ARGX Nasdaq
  • Market Cap
  • STZ 34.3B
  • ARGX 40.4B
  • IPO Year
  • STZ 1987
  • ARGX 2017
  • Fundamental
  • Price
  • STZ $190.09
  • ARGX $549.65
  • Analyst Decision
  • STZ Buy
  • ARGX Strong Buy
  • Analyst Count
  • STZ 18
  • ARGX 20
  • Target Price
  • STZ $225.11
  • ARGX $698.22
  • AVG Volume (30 Days)
  • STZ 1.6M
  • ARGX 423.4K
  • Earning Date
  • STZ 07-02-2025
  • ARGX 05-08-2025
  • Dividend Yield
  • STZ 2.15%
  • ARGX N/A
  • EPS Growth
  • STZ N/A
  • ARGX N/A
  • EPS
  • STZ N/A
  • ARGX 15.94
  • Revenue
  • STZ $10,208,700,000.00
  • ARGX $2,643,062,000.00
  • Revenue This Year
  • STZ N/A
  • ARGX $60.97
  • Revenue Next Year
  • STZ $1.41
  • ARGX $31.50
  • P/E Ratio
  • STZ N/A
  • ARGX $32.07
  • Revenue Growth
  • STZ 2.48
  • ARGX 82.13
  • 52 Week Low
  • STZ $160.46
  • ARGX $352.77
  • 52 Week High
  • STZ $265.70
  • ARGX $678.21
  • Technical
  • Relative Strength Index (RSI)
  • STZ 59.87
  • ARGX 36.21
  • Support Level
  • STZ $185.57
  • ARGX $529.11
  • Resistance Level
  • STZ $192.61
  • ARGX $658.93
  • Average True Range (ATR)
  • STZ 3.28
  • ARGX 17.55
  • MACD
  • STZ 0.29
  • ARGX -6.04
  • Stochastic Oscillator
  • STZ 74.77
  • ARGX 15.82

About STZ Constellation Brands Inc.

Constellation Brands is the largest provider of alcoholic beverages across the beer, wine, and spirits categories in the U.S., generating 80% of revenue from Mexican beer imports under top-selling brands such as Modelo and Corona. The rest of the business includes some remaining wine and spirits brands, categories where the company continue to prune assets in recent years. With its exclusive rights tied to the Mexican beer brands effective only in the U.S., the firm has small revenue exposure to international markets. Constellation owns a 36% stake in no-moat Canopy Growth, a medicinal and recreational cannabis producer in Canada, and has a 50/50 joint venture with glass manufacturer Owens-Illinois in Mexico.

About ARGX argenx SE

Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.

Share on Social Networks: